Views & Analysis Real-world or real evidence? There was a time when the distinction between data from clinical trials and data from any other source was clear.
Views & Analysis Nine for 2019: Opportunities for pharma In the last Nine for 2019 article, we reflected on the major challenges that are sha
R&D Boosting clinical trial productivity to prove Eroom wrong According to Eroom’s law, drug discovery becomes slower and costlier over time. And the data are, at least in part, bearing that out.
Views & Analysis Real-world data – optimising your strategy for market access... The points to consider in preparing an effective data strategy.
Views & Analysis Innovations in cancer drug research While cancer continues to be one of the leading causes of death and illness, new technology and increasing use of real-world data have the potential to revolutionise care.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
